Rely on Worldwide to Drive the Success of Your Myocardial Ischemia Clinical Trial

For many people suffering with myocardial ischemia – the reduction of blood flow to the heart – the underlying cause is a buildup of plaque within the coronary arteries. Restoring blood flow is the key to reducing myocardial ischemia, but there are serious challenges with this solution.

Can you reduce the plaque buildup without rupturing the plaques? Can you find other ways to increase blood flow to the heart itself?

Given that nearly 800,000 Americans experience myocardial infarction each year and that myocardial ischemia is often a precursor to such events, reducing the incidence of myocardial ischemia is of paramount concern. This is one reason why Worldwide Clinical Trials is dedicated to helping researchers conduct complex cardiovascular studies.

Our experience spans Phase I through Phase IV clinical trials and real-world evidence, from coronary artery disease and heart failure to arterial hypertension and peripheral vascular disease. If you’re investigating interventions for myocardial ischemia and seek an uncommon team of experts with global reach and unparalleled experience, look no further than Worldwide Clinical Trials.